Skip to content

Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions

McMaster Choices Study: Evaluating the Impact of Cancer Screening Patient Decision Aids on Breast Cancer Screening Decisions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03631758
Enrollment
209
Registered
2018-08-15
Start date
2019-01-01
Completion date
2020-12-01
Last updated
2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Screening, Mammography, Patient Decision Aid

Brief summary

Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health care provider with their personal needs, values and preferences. Through this project, Dr. Dobbins and her research team will explore whether the use of patient decision aids with high-quality and user-friendly summaries of research evidence, or summaries of research evidence alone, help to improve the quality of decision making by women facing breast cancer screening decisions.

Detailed description

Guidelines for breast screening in Canada are based on low-moderate quality evidence of effectiveness and screening is associated with potential harms. Patient Decision Aids (PDAs) are tools that assist users to understand treatment options, risks and benefits to align decisions with values and preferences. The investigators would now like to know whether use of a PDA alongside evidence-based information provided through the McMaster Optimal Aging Portal, or simply access to evidence-based information alone, can help users to make informed decisions about breast cancer screening in women.

Interventions

Evidence-based information on mammography such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources).

Patient Decision Aid for breast cancer screening decision

Educational information not specific to mammography or cancer screening

Sponsors

Canadian Cancer Society (CCS)
CollaboratorOTHER
McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* English speaking women, 40-49 years old * Residents of British Columbia, Nova Scotia, and Prince Edward Island

Exclusion criteria

* History of breast cancer or mammography in the last 12 months * Classified as above-average risk for breast cancer (i.e., known genetic mutation linked to BC; no genetic testing, but a parent, sibling or child with a genetic mutation linked to BC; or received chest wall radiation before age 30)

Design outcomes

Primary

MeasureTime frameDescription
Decisional Conflict ScaleChange from baseline to 6-moA validated scale in which items are summed and scored to create a total score. Scores range from 0 to 100, with higher scores indicating higher decisional conflict.

Secondary

MeasureTime frameDescription
Decision qualityChange from baseline to 6-moDecision Quality Worksheet for Mammography
Preparation for Decision Making ScaleChange from baseline to 6-moA validated scale, items are summed and scored to create a score of 0-100. Higher scores indicate higher preparation for decision making
Screening behaviourChange from baseline to 6-moCongruency between self-reported screening status and stated decision

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026